Table 1.
Demographic and clinical characteristics of cancer cases for overall survival (OS) by cancer type, Shanghai, China
| Breast cancer |
Colorectal cancer |
Lung cancer |
Gastric cancer |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No. of deaths/participants | 3-Yr/5-Yr OS rate (%)a) | p-value | No. of deaths/participants | 3-Yr/5-Yr OS rate (%)a) | p-value | No. of deaths/participants | 3-Yr/5-Yr OS rate (%)a) | p-value | No. of deaths/participants | 3-Yr/5-Yr OS rate (%)a) | p-value | |
| Overall survival | 107/633 | 92.7/87.6 | n/a | 383/890 | 65.9/58.4 | n/a | 681/824 | 26.2/18.3 | n/a | 357/543 | 42.3/36.7 | n/a |
| Sex | ||||||||||||
| Female | 107/633 | 92.7/87.6 | n/a | 197/477 | 66.4/60.0 | 0.27 | 271/340 | 32.1/22.6 | < 0.01 | 135/203 | 40.4/35.5 | 0.59 |
| Male | n/a | n/a | 186/413 | 65.2/56.6 | 410/484 | 22.1/15.2 | 222/340 | 43.5/37.4 | ||||
| Education (%) | ||||||||||||
| ≤ High school | 75/340 | 90.9/83.9 | < 0.01 | 235/513 | 63.1/55.4 | 0.04 | 466/534 | 21.2/13.6 | < 0.01 | 229/329 | 37.4/32.0 | < 0.01 |
| > High school | 32/293 | 94.9/91.6 | 148/377 | 69.7/62.4 | 215/290 | 35.5/26.9 | 128/214 | 50.0/43.6 | ||||
| Body mass index (kg/m2) | ||||||||||||
| < 25 | 51/365 | 93.2/90.1 | < 0.01 | 224/508 | 65.3/58.3 | 0.03 | 464/563 | 26.6/18.6 | 0.59 | 208/321 | 44.8/38.2 | 0.54 |
| 25-29 | 44/228 | 93.0/85.7 | 131/333 | 69.0/60.7 | 179/221 | 25.8/19.0 | 131/196 | 38.8/35.2 | ||||
| ≥ 30 | 12/40 | 87.5/75.0 | 28/49 | 50.6/43.1 | 38/40 | 22.5/10.0 | 18/26 | 38.5/29.9 | ||||
| Exercise regularly (%) | ||||||||||||
| No | 71/427 | 92.7/87.6 | 0.78 | 209/494 | 67.2/59.2 | 0.73 | 392/486 | 28.4/19.9 | 0.01 | 190/296 | 43.2/37.9 | 0.79 |
| Yes | 36/206 | 92.7/87.5 | 174/396 | 64.1/57.4 | 289/338 | 23.1/15.9 | 167/247 | 41.3/35.3 | ||||
| Smoking status | ||||||||||||
| Never | 102/621 | 93.1/87.8 | 0.03 | 256/607 | 65.8/58.9 | 0.55 | 295/374 | 32.6/23.7 | < 0.01 | 192/296 | 41.6/36.5 | 0.87 |
| Current/Former | 5/12 | 75.0/75.0 | 127/283 | 65.9/57.3 | 386/450 | 20.9/13.8 | 165/247 | 43.3/36.9 | ||||
| Comorbidity | ||||||||||||
| No | 92/576 | 93.2/88.3 | 0.04 | 239/625 | 68.6/61.9 | < 0.01 | 415/515 | 28.9/20.9 | 0.01 | 214/334 | 40.7/36.4 | 0.98 |
| yes | 15/57 | 87.7/80.3 | 144/265 | 59.5/50.7 | 266/309 | 21.7/13.8 | 143/209 | 45.0/37.2 | ||||
| Age at cancer diagnosis (yr) | ||||||||||||
| 40-49 | 5/52 | 98.1/96.2 | 0.01 | 10/24 | 70.8/66.7 | < 0.01 | 22/31 | 41.9/35.0 | < 0.01 | 17/28 | 57.1/45.9 | 0.03 |
| 50-59 | 42/280 | 93.6/89.5 | 58/189 | 75.6/71.7 | 125/173 | 37.6/29.2 | 70/120 | 47.4/43.1 | ||||
| ≥ 60 | 60/301 | 91.0/84.3 | 315/677 | 63.0/54.3 | 534/620 | 22.3/14.3 | 270/395 | 39.7/34.2 | ||||
| TNM stage | ||||||||||||
| Stage I | 13/202 | 98.0/95.3 | < 0.01 | 30/188 | 93.6/85.6 | < 0.01 | 16/58 | 84.5/73.5 | < 0.01 | 23/99 | 90.9/84.4 | < 0.01 |
| Stage II | 41/289 | 95.2/91.1 | 58/198 | 79.1/72.3 | 41/87 | 59.8/52.4 | 73/129 | 51.9/44.5 | ||||
| Stage III | 20/43 | 69.8/67.4 | 122/247 | 61.8/52.2 | 79/96 | 34.4/18.3 | 56/67 | 28.4/16.9 | ||||
| Stage IV | 8/12 | 41.7/31.3 | 88/94 | 10.3/6.2 | 278/287 | 11.5/3.1 | 84/88 | 5.2/3.5 | ||||
| Unknown | 25/87 | 90.8/76.1 | 85/163 | 55.8/49.4 | 267/296 | 16.6/12.0 | 121/160 | 30.6/26.6 | ||||
| Chemotherapy | ||||||||||||
| No | 19/81 | 90.1/81.7 | 0.08 | 125/236 | 54.6/47.4 | < 0.01 | 280/326 | 20.3/15.6 | < 0.01 | 140/198 | 36.9/31.5 | < 0.01 |
| Yes | 88/552 | 93.1/88.5 | 258/654 | 69.9/62.4 | 401/498 | 30.1/20.1 | 217/345 | 45.5/39.7 | ||||
| Radiotherapy | ||||||||||||
| No | 81/497 | 93.8/87.7 | 0.55 | 349/837 | 67.4/59.6 | < 0.01 | 545/668 | 27.0/19.9 | 0.91 | 350/532 | 42.5/36.7 | 0.80 |
| Yes | 26/136 | 89.0/87.3 | 34/53 | 41.1/39.1 | 136/156 | 23.1/11.2 | 7/11 | 36.4/36.4 | ||||
| Surgery | ||||||||||||
| No | 11/17 | 58.8/32.7 | < 0.01 | 66/80 | 18.8/17.4 | < 0.01 | 518/539 | 10.8/4.1 | < 0.01 | 119/131 | 12.2/9.4 | < 0.01 |
| Yes | 96/616 | 93.7/89.1 | 317/810 | 70.5/62.4 | 163/285 | 55.4/44.6 | 238/412 | 51.9/45.4 | ||||
a)
Survival rate calculated using life table analysis method.